Drager enters $150 million Euro resuscitation market:
This article was originally published in Clinica
Lubeck, Germany-based Drager Medical, a manufacturer of medical equipment for the clinical acute care and homecare sectors, has agreed to distribute Zoll Medical's resuscitation products in certain European markets. Included in the agreement are Zoll's M Series defibrillator and its new first-responder defibrillator, the ZOLL AED Plus - both of which incorporate the Burlington, Massachusetts-based company's proprietary rectilinear biphasic waveform technology. The European market for resuscitation products is worth an estimated $150m, Zoll says.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.